SOSV

Ostoform Limited is a medical device company based in Dublin, Ireland, focused on improving skin health for individuals with ostomies. Founded in 2016 as a spin-out from the University of Limerick, Ostoform develops patented technologies aimed at managing and reducing skin complications associated with ostomies. The company's primary products include a mouldable seal that fits securely around the stoma and FLOWASSIST, which directs stoma output away from the skin. By effectively guiding the corrosive output into the ostomy bag, these products help prevent skin irritation and swelling, enhancing patient comfort and quality of life. Ostoform aims to become a global leader in the ostomy skin health market, leveraging its innovative solutions to address the needs of ostomy patients.

XFuel is a company that specializes in producing sustainable and net-zero drop-in fuels for road, marine, and aviation applications. Founded in 2010 and headquartered in Dublin, Ireland, with a presence in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient and cost-effective conversion of biomass waste into low-carbon fuels. The company’s advanced fuels generate up to 85% fewer greenhouse gas emissions compared to conventional fossil fuel production, positioning them as a cleaner alternative in the transport sector. By providing decentralized and sustainable fuel solutions, XFuel aims to support distributors and consumers globally in reducing reliance on fossil fuels while working towards carbon-neutral and even carbon-negative fuel options.

Oxyle AG is a Swiss company based in Zurich that specializes in wastewater treatment aimed at removing persistent and toxic micropollutants from water sources. Established in 2020, the company has developed a novel technology that effectively degrades hazardous substances, including pharmaceuticals, personal-care products, endocrine-disrupting chemicals, pesticides, and industrial chemicals. Oxyle serves a diverse clientele, including the pharmaceutical, biotech, chemical, food and beverage sectors, research laboratories, hospitals, and wastewater treatment facilities. Its innovative approach not only helps clients comply with regulatory standards but also offers a sustainable alternative to wastewater incineration, thereby contributing to reduced CO2 emissions.

Reach Industries, founded in 2020 and headquartered in Bristol, UK, is a software development company that specializes in creating advanced products for laboratories. The company develops a platform aimed at enhancing productivity and quality in lab environments. Its robotics software supports scientists by improving laboratory efficiency through features such as predictive quality and maintenance analytics, asset condition monitoring, and process optimization. This innovative approach enables clients to effectively manage material flow and securely store telematics and sensor data in the cloud.

Samphire Neuroscience is a neurotechnology company based in London, England, founded in 2021. The company focuses on women's health and lifestyle enhancement through innovative solutions. Its primary product is a headband device that employs non-invasive electrical neuromodulation to stimulate specific areas of the brain. This technology aims to alleviate symptoms commonly associated with menstrual cycles, including pain, fatigue, and mood disturbances, thereby improving the overall well-being of women.

Vitarka Therapeutics is a London-based company focused on developing medical technologies and solutions for various types of cancer. The company has created a targeted non-viral delivery platform aimed at intracellular targets in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage patients suffering from lung, colon, breast, and other cancers. By utilizing re-engineered pore-forming proteins for cell-specific targeting and facilitating the endosomal release of therapeutic cargo, Vitarka Therapeutics aims to provide cancer patients with renewed hope and the potential to lead more normal lives.

Machine Medicine Technologies Ltd, established in 2017 and based in London, UK, specializes in developing artificial intelligence-driven solutions for healthcare. The company's core product, KELVIN-PD, employs computer vision and pose estimation to objectively measure and analyze movement in patients, particularly those with Parkinson's disease. This platform delivers precise metrics, such as tremor and bradykinesia, from simple video clips, enabling secure, device-agnostic, and affordable patient data management.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

GlowDx is a diagnostics company based in Midleton, Ireland, established in 2015. The company focuses on decentralizing molecular testing through innovative point-of-care technologies, which facilitate local access to diagnostics for tropical diseases. By combining novel molecular technology with effective delivery models, GlowDx aims to improve clinical outcomes while reducing the economic burden on patients and healthcare systems. This approach enhances the quality of life for individuals by ensuring they receive timely and accurate diagnostic information, thereby enabling healthcare providers to offer better-targeted treatments.

XFuel is a company that specializes in producing sustainable and net-zero drop-in fuels for road, marine, and aviation applications. Founded in 2010 and headquartered in Dublin, Ireland, with a presence in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient and cost-effective conversion of biomass waste into low-carbon fuels. The company’s advanced fuels generate up to 85% fewer greenhouse gas emissions compared to conventional fossil fuel production, positioning them as a cleaner alternative in the transport sector. By providing decentralized and sustainable fuel solutions, XFuel aims to support distributors and consumers globally in reducing reliance on fossil fuels while working towards carbon-neutral and even carbon-negative fuel options.

Sundew is a biotechnology company founded in 2018 and headquartered in Copenhagen. The company specializes in providing biological services designed to treat aquatic pests and diseases through innovative solutions. Utilizing precision fermentation, Sundew develops environmentally-friendly products aimed at addressing challenges in the aquaculture market, including the management of invasive species and ecological issues such as red tides. By focusing on unmet needs within this sector, Sundew enables its clients to create effective, cost-efficient solutions that are both climate-friendly and sustainable.

CroBio Ltd is an agricultural biotechnology company based in Macclesfield, United Kingdom, founded in 2019 by experts in microbiology and engineering. The company focuses on developing environmentally sustainable solutions to combat global agricultural drought. Its technology leverages genetically engineered root-associated bacteria that produce a sponge-like biomaterial, facilitating biologically active water retention in soil. This innovative approach aims to improve soil health and enhance water management in agricultural practices.

NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.

Samphire Neuroscience is a neurotechnology company based in London, England, founded in 2021. The company focuses on women's health and lifestyle enhancement through innovative solutions. Its primary product is a headband device that employs non-invasive electrical neuromodulation to stimulate specific areas of the brain. This technology aims to alleviate symptoms commonly associated with menstrual cycles, including pain, fatigue, and mood disturbances, thereby improving the overall well-being of women.

CargoKite, founded in 2022 and based in Munich, Germany, specializes in micro cargo ships aimed at transforming maritime logistics. The company designs sailing cargo vessels that harness high-altitude winds for propulsion, allowing for emission-free operations. This innovative approach enhances the efficiency of small ship operations while minimizing personnel costs through digitization. By eliminating the need for large energy storage, CargoKite facilitates decarbonization in the shipping industry, offering clients a sustainable and flexible solution for their logistics needs.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

CroBio Ltd is an agricultural biotechnology company based in Macclesfield, United Kingdom, founded in 2019 by experts in microbiology and engineering. The company focuses on developing environmentally sustainable solutions to combat global agricultural drought. Its technology leverages genetically engineered root-associated bacteria that produce a sponge-like biomaterial, facilitating biologically active water retention in soil. This innovative approach aims to improve soil health and enhance water management in agricultural practices.

NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.

Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.

Reach Industries, founded in 2020 and headquartered in Bristol, UK, is a software development company that specializes in creating advanced products for laboratories. The company develops a platform aimed at enhancing productivity and quality in lab environments. Its robotics software supports scientists by improving laboratory efficiency through features such as predictive quality and maintenance analytics, asset condition monitoring, and process optimization. This innovative approach enables clients to effectively manage material flow and securely store telematics and sensor data in the cloud.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

Samphire Neuroscience is a neurotechnology company based in London, England, founded in 2021. The company focuses on women's health and lifestyle enhancement through innovative solutions. Its primary product is a headband device that employs non-invasive electrical neuromodulation to stimulate specific areas of the brain. This technology aims to alleviate symptoms commonly associated with menstrual cycles, including pain, fatigue, and mood disturbances, thereby improving the overall well-being of women.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.

Vitarka Therapeutics is a London-based company focused on developing medical technologies and solutions for various types of cancer. The company has created a targeted non-viral delivery platform aimed at intracellular targets in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage patients suffering from lung, colon, breast, and other cancers. By utilizing re-engineered pore-forming proteins for cell-specific targeting and facilitating the endosomal release of therapeutic cargo, Vitarka Therapeutics aims to provide cancer patients with renewed hope and the potential to lead more normal lives.

Sundew is a biotechnology company founded in 2018 and headquartered in Copenhagen. The company specializes in providing biological services designed to treat aquatic pests and diseases through innovative solutions. Utilizing precision fermentation, Sundew develops environmentally-friendly products aimed at addressing challenges in the aquaculture market, including the management of invasive species and ecological issues such as red tides. By focusing on unmet needs within this sector, Sundew enables its clients to create effective, cost-efficient solutions that are both climate-friendly and sustainable.

PILI Inc. is a company based in Paris, France, that specializes in researching and manufacturing bio-fabricated colors derived from microorganisms. Founded in 2012, the company focuses on designing enzymes and fermentation biotechnologies that convert sugar into sustainable and long-lasting dyes and pigments. PILI produces renewable inks as an eco-friendly alternative to traditional toxic and non-recyclable options. The company emerged from a collaboration among a biologist, a designer, and a financial analyst in a biohacker space, leading to the creation of innovative products like a pen fed by bacteria. By utilizing microorganisms, PILI aims to replace petrochemical and non-sustainable vegetable dyes, promoting sustainable development while also helping businesses reduce costs.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

CroBio Ltd is an agricultural biotechnology company based in Macclesfield, United Kingdom, founded in 2019 by experts in microbiology and engineering. The company focuses on developing environmentally sustainable solutions to combat global agricultural drought. Its technology leverages genetically engineered root-associated bacteria that produce a sponge-like biomaterial, facilitating biologically active water retention in soil. This innovative approach aims to improve soil health and enhance water management in agricultural practices.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.

Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Oxyle AG is a Swiss company based in Zurich that specializes in wastewater treatment aimed at removing persistent and toxic micropollutants from water sources. Established in 2020, the company has developed a novel technology that effectively degrades hazardous substances, including pharmaceuticals, personal-care products, endocrine-disrupting chemicals, pesticides, and industrial chemicals. Oxyle serves a diverse clientele, including the pharmaceutical, biotech, chemical, food and beverage sectors, research laboratories, hospitals, and wastewater treatment facilities. Its innovative approach not only helps clients comply with regulatory standards but also offers a sustainable alternative to wastewater incineration, thereby contributing to reduced CO2 emissions.

Vitarka Therapeutics is a London-based company focused on developing medical technologies and solutions for various types of cancer. The company has created a targeted non-viral delivery platform aimed at intracellular targets in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage patients suffering from lung, colon, breast, and other cancers. By utilizing re-engineered pore-forming proteins for cell-specific targeting and facilitating the endosomal release of therapeutic cargo, Vitarka Therapeutics aims to provide cancer patients with renewed hope and the potential to lead more normal lives.

Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.

Samphire Neuroscience is a neurotechnology company based in London, England, founded in 2021. The company focuses on women's health and lifestyle enhancement through innovative solutions. Its primary product is a headband device that employs non-invasive electrical neuromodulation to stimulate specific areas of the brain. This technology aims to alleviate symptoms commonly associated with menstrual cycles, including pain, fatigue, and mood disturbances, thereby improving the overall well-being of women.

Machine Medicine Technologies Ltd, established in 2017 and based in London, UK, specializes in developing artificial intelligence-driven solutions for healthcare. The company's core product, KELVIN-PD, employs computer vision and pose estimation to objectively measure and analyze movement in patients, particularly those with Parkinson's disease. This platform delivers precise metrics, such as tremor and bradykinesia, from simple video clips, enabling secure, device-agnostic, and affordable patient data management.

Reach Industries, founded in 2020 and headquartered in Bristol, UK, is a software development company that specializes in creating advanced products for laboratories. The company develops a platform aimed at enhancing productivity and quality in lab environments. Its robotics software supports scientists by improving laboratory efficiency through features such as predictive quality and maintenance analytics, asset condition monitoring, and process optimization. This innovative approach enables clients to effectively manage material flow and securely store telematics and sensor data in the cloud.

ChronosDx is a biotechnology research company based in London, Germany, specializing in drug development and in vitro diagnostics. The firm focuses on creating bioassay technology tailored for diagnostics, drug screening, and development. ChronosDx develops high-performance, cost-effective, and scalable technology that effectively detects various biomarkers, including cell-free DNA, micro proteins, exosomes, and metabolites. This innovative platform enables medical professionals to monitor biomarkers both in-line and in vivo, enhancing the capabilities of healthcare diagnostics.

GlowDx is a diagnostics company based in Midleton, Ireland, established in 2015. The company focuses on decentralizing molecular testing through innovative point-of-care technologies, which facilitate local access to diagnostics for tropical diseases. By combining novel molecular technology with effective delivery models, GlowDx aims to improve clinical outcomes while reducing the economic burden on patients and healthcare systems. This approach enhances the quality of life for individuals by ensuring they receive timely and accurate diagnostic information, thereby enabling healthcare providers to offer better-targeted treatments.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

XFuel is a company that specializes in producing sustainable and net-zero drop-in fuels for road, marine, and aviation applications. Founded in 2010 and headquartered in Dublin, Ireland, with a presence in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient and cost-effective conversion of biomass waste into low-carbon fuels. The company’s advanced fuels generate up to 85% fewer greenhouse gas emissions compared to conventional fossil fuel production, positioning them as a cleaner alternative in the transport sector. By providing decentralized and sustainable fuel solutions, XFuel aims to support distributors and consumers globally in reducing reliance on fossil fuels while working towards carbon-neutral and even carbon-negative fuel options.

CargoKite, founded in 2022 and based in Munich, Germany, specializes in micro cargo ships aimed at transforming maritime logistics. The company designs sailing cargo vessels that harness high-altitude winds for propulsion, allowing for emission-free operations. This innovative approach enhances the efficiency of small ship operations while minimizing personnel costs through digitization. By eliminating the need for large energy storage, CargoKite facilitates decarbonization in the shipping industry, offering clients a sustainable and flexible solution for their logistics needs.

SensiPass Ltd. specializes in developing advanced 3-factor authentication solutions aimed at enhancing digital security for various industries, including energy, transportation, communications, government, and defense. Established in 2013 and headquartered in Dublin, Ireland, the company addresses significant challenges related to identity theft and insider threats by replacing traditional passwords and PINs with a personalized human interaction model. By registering a user's device, biometric data, and a unique interaction, SensiPass generates a sophisticated digital signature that is secure and non-reproducible. This innovative approach allows for quick authentication, providing identity assurance in both digital and physical access scenarios. The company's patented technologies, such as SensiAR™ and ImmersiveID™, cater to immersive environments, reinforcing security for critical infrastructure and utilities. SensiPass has received recognition for its contributions to cybersecurity innovation, including accolades from Deloitte and other industry organizations.

Moona, established in 2016 and based in Paris, France, specializes in innovative sleep technology. The company's flagship product is a smart, water-based cooling and heating pillow pad system that actively regulates body temperature to enhance sleep quality. By gently adjusting head temperature throughout the night, Moona aims to create a more comfortable and restful sleep environment.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

IPOR Labs is a company based in Zug, Switzerland, that focuses on the development of blockchain-based derivatives software aimed at fixing interest rates. The firm's primary offering, the IPOR Protocol, comprises three components: the IPOR Index, Interest Rate Derivatives, and a Liquidity Pool with an Automated Market Maker (AMM). This software allows users to engage in interest rate swaps, providing a contract counterparty through the liquidity pool. Participants can choose between fixed or floating rates based on the prevailing IPOR rate, thereby gaining transparent oversight and control over their borrowing costs in the decentralized finance (DeFi) market.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

SunGreenH2 is a company focused on producing green hydrogen through advanced nanotechnology and proprietary electrolysis systems. Founded in 2020 and headquartered in Singapore, with additional offices in Melbourne and London, the company has developed a modular and scalable electrolyser stack that enables efficient on-site hydrogen production using only sunlight and water. This innovative approach results in zero emissions and significantly reduces costs, facilitating the widespread adoption of green hydrogen across various sectors, including transportation, energy storage, and specialty chemicals. With over a decade of research in electrochemistry and nanotechnology, SunGreenH2 aims to unlock sustainable and scalable hydrogen solutions for industries worldwide.

AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Sundew is a biotechnology company founded in 2018 and headquartered in Copenhagen. The company specializes in providing biological services designed to treat aquatic pests and diseases through innovative solutions. Utilizing precision fermentation, Sundew develops environmentally-friendly products aimed at addressing challenges in the aquaculture market, including the management of invasive species and ecological issues such as red tides. By focusing on unmet needs within this sector, Sundew enables its clients to create effective, cost-efficient solutions that are both climate-friendly and sustainable.

Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.

ROVENSO is a Swiss company founded in 2016 and headquartered in Villaz-Saint-Pierre, Switzerland, with additional facilities in Shenzhen, China. The company specializes in the development and manufacturing of remotely operated robots designed for challenging environments, focusing on security monitoring, safety assessment, and anomaly detection. Its flagship product, ROVéo, is a four-wheeled rover capable of operating autonomously around the clock in industrial settings, providing cost-effective security solutions that are two to three times more efficient than traditional manned guarding. ROVéo is equipped to patrol both indoor and outdoor spaces, detecting intrusions, thefts, and potential safety hazards such as fires or gas leaks, which can be critical for protecting lives and property. ROVENSO's innovations also include a lightweight immersive control station, LISéo, which enhances the operational capabilities of its robotic systems.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

Quidli is a technological infrastructure company based in Paris, France, that focuses on connecting companies and workers through the exchange of equity for labor. Founded in 2018, Quidli's platform allows businesses to split ownership equity as a form of compensation, facilitating a direct link between companies, freelancers, and investors. By leveraging blockchain technology, the platform provides a means for organizations to incentivize contributions from individuals, enhancing employee engagement and productivity. Additionally, it offers job security for workers by allowing them to pursue projects of their choice, while companies can utilize the platform for recruitment purposes.

Samphire Neuroscience is a neurotechnology company based in London, England, founded in 2021. The company focuses on women's health and lifestyle enhancement through innovative solutions. Its primary product is a headband device that employs non-invasive electrical neuromodulation to stimulate specific areas of the brain. This technology aims to alleviate symptoms commonly associated with menstrual cycles, including pain, fatigue, and mood disturbances, thereby improving the overall well-being of women.

Reach Industries, founded in 2020 and headquartered in Bristol, UK, is a software development company that specializes in creating advanced products for laboratories. The company develops a platform aimed at enhancing productivity and quality in lab environments. Its robotics software supports scientists by improving laboratory efficiency through features such as predictive quality and maintenance analytics, asset condition monitoring, and process optimization. This innovative approach enables clients to effectively manage material flow and securely store telematics and sensor data in the cloud.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Ostoform Limited is a medical device company based in Dublin, Ireland, focused on improving skin health for individuals with ostomies. Founded in 2016 as a spin-out from the University of Limerick, Ostoform develops patented technologies aimed at managing and reducing skin complications associated with ostomies. The company's primary products include a mouldable seal that fits securely around the stoma and FLOWASSIST, which directs stoma output away from the skin. By effectively guiding the corrosive output into the ostomy bag, these products help prevent skin irritation and swelling, enhancing patient comfort and quality of life. Ostoform aims to become a global leader in the ostomy skin health market, leveraging its innovative solutions to address the needs of ostomy patients.

Intelligent Implants, established in 2014 in Cork, Ireland, specializes in developing innovative, wireless, implantable electronic devices. The company focuses on stimulating, steering, and monitoring bone growth, aiding in the recovery of bone and other tissues. Their electrotherapeutic devices, powered by data, engineering, and medical expertise, facilitate both patient treatment and informed decision-making by healthcare professionals. Co-founded by Erik Zellmer, Rory Murphy, Martin Larsson, and John Zellmer, Intelligent Implants aims to revolutionize bone healing and tissue regeneration through its connected medical technologies.

Kyomei is a company based in Oxford, England, founded in 2021, that focuses on developing a plant-based production system aimed at creating animal proteins for the alternative meat industry. Utilizing innovative plant cell biology, Kyomei employs a unique method to scale the production of myoglobin in plants, which enhances the umami flavor of meat alternatives. This approach not only improves the taste of plant-based products but also supports efforts to reduce carbon emissions associated with traditional animal farming. Through its sustainable practices, Kyomei aims to provide consumers with flavorful plant-based meat options while contributing to a more environmentally friendly food system.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Kutanios is a biotechnology company based in London that specializes in the development of innovative compounds for various skincare applications, including anti-aging, sun protection, and anti-acne treatments. The firm focuses on creating biodegradable molecules that utilize a novel mechanism of action, which targets lipid peroxides generated by environmental factors such as sunlight, pollution, and tobacco smoke. By employing green technology in the manufacturing process, Kutanios aims to provide effective solutions that help prevent skin aging, sunburn, and skin cancers, catering to the needs of consumers seeking safer and more effective skincare options.

Kutanios is a biotechnology company based in London that specializes in the development of innovative compounds for various skincare applications, including anti-aging, sun protection, and anti-acne treatments. The firm focuses on creating biodegradable molecules that utilize a novel mechanism of action, which targets lipid peroxides generated by environmental factors such as sunlight, pollution, and tobacco smoke. By employing green technology in the manufacturing process, Kutanios aims to provide effective solutions that help prevent skin aging, sunburn, and skin cancers, catering to the needs of consumers seeking safer and more effective skincare options.

IPOR Labs is a company based in Zug, Switzerland, that focuses on the development of blockchain-based derivatives software aimed at fixing interest rates. The firm's primary offering, the IPOR Protocol, comprises three components: the IPOR Index, Interest Rate Derivatives, and a Liquidity Pool with an Automated Market Maker (AMM). This software allows users to engage in interest rate swaps, providing a contract counterparty through the liquidity pool. Participants can choose between fixed or floating rates based on the prevailing IPOR rate, thereby gaining transparent oversight and control over their borrowing costs in the decentralized finance (DeFi) market.

VoltStorage GmbH, based in Olching, Germany, specializes in developing and producing power storage devices that utilize eco-friendly redox flow technology. The company's flagship product, VoltStorage, is a vanadium redox flow battery system designed to store excess electricity generated by solar panels during the day for use at night. This innovative approach enables homeowners to access renewable energy around the clock, promoting sustainability and environmental responsibility. In addition to its products, VoltStorage offers installation and technical support services, ensuring customers can effectively integrate these systems into their homes. The company aims to make renewable energy more accessible and contribute to a cleaner, fairer world for future generations.

Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.

Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

Intelligent Implants, established in 2014 in Cork, Ireland, specializes in developing innovative, wireless, implantable electronic devices. The company focuses on stimulating, steering, and monitoring bone growth, aiding in the recovery of bone and other tissues. Their electrotherapeutic devices, powered by data, engineering, and medical expertise, facilitate both patient treatment and informed decision-making by healthcare professionals. Co-founded by Erik Zellmer, Rory Murphy, Martin Larsson, and John Zellmer, Intelligent Implants aims to revolutionize bone healing and tissue regeneration through its connected medical technologies.

Caura Ltd. is a London-based company established in 2018 that specializes in vehicle management solutions. The company offers a platform that enables drivers to efficiently handle various aspects of car ownership, including payments for parking, tolls, congestion charges, MOTs, vehicle tax, and insurance. Additionally, Caura provides a product called Caura Protect, which allows users to purchase and manage motor insurance through a network of insurers. The company also focuses on developing microelectronic devices that monitor health metrics such as lactate and glucose levels, along with heart-rate and accelerometry data. Furthermore, Caura creates application software that connects to these devices to generate reports and analyze the collected data.

Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in the US and Portugal.

Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.

Nordetect, based in Copenhagen and founded in 2016, is an analytical hardware company that specializes in Lab-on-a-chip devices designed for environmental and agricultural analysis. The company aims to integrate medical-grade technology into the farming sector, offering solutions for nutrient analysis to optimize crop performance. Nordetect's technology enables farm managers, agricultural service providers, and indoor growers to conduct reliable and affordable testing of soil nutrients, specifically nitrogen, phosphorus, and potassium. By providing clear and actionable data, the company helps users make informed decisions about fertilizer usage and agricultural practices, ultimately leading to improved harvests.

ScanTrust SA is a Swiss company that specializes in a cloud-based IoT platform aimed at enhancing product and packaging security through unique identifiers. Founded in 2014 and with operations in cities such as Shanghai, Singapore, and Bangkok, ScanTrust provides a suite of tools including a printer portal for packaging partners to integrate secure codes into their processes, and Scan-data, an online portal for real-time business intelligence and supply chain insights. Additionally, the platform enables product authentication and supply chain traceability using QR codes, which can be verified through mobile applications. By protecting brands and facilitating consumer engagement, ScanTrust helps companies navigate the complexities of selling physical products in a connected market.

SunGreenH2 is a company focused on producing green hydrogen through advanced nanotechnology and proprietary electrolysis systems. Founded in 2020 and headquartered in Singapore, with additional offices in Melbourne and London, the company has developed a modular and scalable electrolyser stack that enables efficient on-site hydrogen production using only sunlight and water. This innovative approach results in zero emissions and significantly reduces costs, facilitating the widespread adoption of green hydrogen across various sectors, including transportation, energy storage, and specialty chemicals. With over a decade of research in electrochemistry and nanotechnology, SunGreenH2 aims to unlock sustainable and scalable hydrogen solutions for industries worldwide.

Nordetect, based in Copenhagen and founded in 2016, is an analytical hardware company that specializes in Lab-on-a-chip devices designed for environmental and agricultural analysis. The company aims to integrate medical-grade technology into the farming sector, offering solutions for nutrient analysis to optimize crop performance. Nordetect's technology enables farm managers, agricultural service providers, and indoor growers to conduct reliable and affordable testing of soil nutrients, specifically nitrogen, phosphorus, and potassium. By providing clear and actionable data, the company helps users make informed decisions about fertilizer usage and agricultural practices, ultimately leading to improved harvests.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

TIER Mobility GmbH is a Berlin-based shared micro-mobility provider founded in 2018, specializing in electric kick scooters, e-bikes, and e-mopeds for local commuting. The company aims to transform urban mobility by offering users a convenient way to access light electric vehicles through its application software, which allows them to locate and book available scooters. TIER is dedicated to promoting climate neutrality and reducing urban dependence on cars, contributing to a more sustainable and livable environment. Through its proprietary Energy Network, TIER strives to enhance the efficiency and accessibility of its services, thereby supporting cities in their efforts to improve mobility solutions.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, specializing in the development of plant-based proteins for the food and beverage industries. Established in 2018, the company focuses on creating innovative protein sweeteners, including brazzein, utilizing its proprietary protein engineering and expression platforms. These novel protein-based molecules are designed to offer non-calorific alternatives that address sugar content and associated health concerns. By providing advanced solutions for the food, health, and nutrition sectors, Magellan Life Sciences aims to meet the growing demand for healthier ingredients in consumer products.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at providing clean air for individuals in polluted megacities such as Beijing and London. The company utilizes patented air purifying technology, which has been independently validated to be significantly more effective than traditional masks, filtering out dust and smoke particles through an active nanofiltration system. This innovative approach allows users to commute and exercise without the risks associated with pollution, promoting respiratory health while ensuring comfort and style. Aō Air's mission focuses on empowering urban residents to reclaim their environment and breathe clean air amidst increasing urban pollution challenges.

Mobio Interactive Inc. specializes in creating digital tools that enhance mental health and well-being for both consumers and clinical populations. Founded in 2014 and headquartered in Toronto, Canada, with additional offices in Zurich, Switzerland, and Shanghai, China, the company has developed applications such as Am Mindfulness, Wildflowers Mindfulness, and Actify Mindfulness. These applications provide medical-grade mindfulness training while objectively measuring the effectiveness of mindfulness practices through advanced analytics. Mobio's AI-powered digital theragnostic platform delivers clinically validated psychotherapy programs tailored to individual patients, utilizing digital biomarkers to assess human brain states without the need for wearable devices. The platform ensures secure and private interactions for users, allowing them to engage with mental health resources from anywhere in the world.

Nordetect, based in Copenhagen and founded in 2016, is an analytical hardware company that specializes in Lab-on-a-chip devices designed for environmental and agricultural analysis. The company aims to integrate medical-grade technology into the farming sector, offering solutions for nutrient analysis to optimize crop performance. Nordetect's technology enables farm managers, agricultural service providers, and indoor growers to conduct reliable and affordable testing of soil nutrients, specifically nitrogen, phosphorus, and potassium. By providing clear and actionable data, the company helps users make informed decisions about fertilizer usage and agricultural practices, ultimately leading to improved harvests.

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

GlowDx is a diagnostics company based in Midleton, Ireland, established in 2015. The company focuses on decentralizing molecular testing through innovative point-of-care technologies, which facilitate local access to diagnostics for tropical diseases. By combining novel molecular technology with effective delivery models, GlowDx aims to improve clinical outcomes while reducing the economic burden on patients and healthcare systems. This approach enhances the quality of life for individuals by ensuring they receive timely and accurate diagnostic information, thereby enabling healthcare providers to offer better-targeted treatments.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

VoltStorage GmbH, based in Olching, Germany, specializes in developing and producing power storage devices that utilize eco-friendly redox flow technology. The company's flagship product, VoltStorage, is a vanadium redox flow battery system designed to store excess electricity generated by solar panels during the day for use at night. This innovative approach enables homeowners to access renewable energy around the clock, promoting sustainability and environmental responsibility. In addition to its products, VoltStorage offers installation and technical support services, ensuring customers can effectively integrate these systems into their homes. The company aims to make renewable energy more accessible and contribute to a cleaner, fairer world for future generations.

Arthronica Ltd is a London-based company that specializes in developing an artificial intelligence platform for patient monitoring and rehabilitation, particularly focused on chronic rheumatic conditions such as arthritis. Established in 2018, the company utilizes advanced technologies, including skeletal tracking, visual strength assessments, image analysis, and video analysis, to create solutions that assist medical practitioners in monitoring and predicting disease activities. Arthronica's innovative system incorporates force-sensing vision and 3D CAD modeling to measure swelling, thereby providing critical insights into disease progression. The company is actively engaged in clinical trials in both the United Kingdom and the United States to further validate its technology and enhance patient care. Additionally, Arthronica has participated in the Entrepreneur First program, which supports individuals in building technology companies.